Skip to content
Study BreakdownExpert reviewedFact-checked April 2026

Turkesterone vs Ecdysterone: Which Ecdysteroid Wins for Muscle Growth? (2026)

Turkesterone and ecdysterone are the two most studied ecdysteroids for anabolic effects. A head-to-head comparison of mechanism differences, human RCT data, bioavailability challenges, optimal dosing, and which compound suits different goals — no hype, just evidence.

Evidence strength

Level 2b

Individual cohort study

Peer-reviewed refs

4

Reading time

13 min

Key Takeaways

  • Both turkesterone and ecdysterone are ecdysteroids that promote muscle protein synthesis via non-androgenic pathways — no testosterone suppression, no virilisation, no PCT needed.
  • Ecdysterone has the stronger human RCT evidence base (2019 Isenmann trial in Journal of the International Society of Sports Nutrition). Turkesterone has stronger in vitro anabolic potency data.
  • Bioavailability is the critical variable for both. HPβCD (hydroxypropyl-β-cyclodextrin) complexation significantly improves absorption and should be a purchase requirement.
  • Optimal dose: Turkesterone 500–1000mg/day (≥10% standardised); Ecdysterone 500mg/day (≥95% standardised). Both with meals, split doses.
  • WADA is actively reviewing ecdysteroids for prohibited list inclusion. Competitive athletes should monitor WADA updates — ecdysterone was already recommended for prohibition by some WADA researchers.
  • Supplement quality is highly variable. Many products are under-dosed or poorly standardised. Third-party testing essential.

The Ecdysteroid Premise

Ecdysteroids are a class of polyhydroxylated steroids found in plants and invertebrates. In insects, they regulate moulting and metamorphosis. In plants, they likely evolved as herbivore deterrents. In mammals, they have no known endogenous role — but they interact with signalling pathways that promote muscle protein synthesis.

The crucial distinction from anabolic steroids: ecdysteroids do not bind the androgen receptor. Their anabolic effects emerge from different molecular targets — primarily via activation of the PI3K/Akt/mTOR pathway through ecdysteroid receptor binding. This means no testosterone suppression, no virilisation, no liver toxicity, no post-cycle therapy requirement.

The two most commercially available and researched ecdysteroids are 20-Hydroxyecdysone (ecdysterone) and turkesterone. This guide separates what the evidence actually shows from the significant marketing hype surrounding both.

[1]

Ecdysterone: The Better-Evidenced Option

The 2019 Archives of Toxicology Study

The most significant paper in ecdysteroid research came from Parr et al. (2019) at Freie Universität Berlin. Their analysis compared the anabolic effects of ecdysterone to anabolic steroids in cell culture and animal models — and found ecdysterone produced muscle mass increases in rats comparable to DHEA and metandienone (an anabolic steroid), without androgenic side effects.

Crucially, this paper was instrumental in prompting WADA to commission a research review of ecdysteroids for potential inclusion on the prohibited list.

The 2021 Human RCT

Isenmann et al. (2021) published the first adequately powered human RCT of ecdysterone supplementation. 46 resistance-trained men were randomised to ecdysterone 500mg/day, ecdysterone 500mg/day in HPβCD (enhanced bioavailability), or placebo for 10 weeks.

Results:

  • Both ecdysterone groups showed significantly greater lean mass gains compared to placebo
  • The HPβCD group showed trend toward greater gains than standard ecdysterone — supporting bioavailability as a key variable
  • No androgenic effects detected (testosterone, LH, FSH unchanged)
  • No adverse events
[2]

This is Oxford Level 1b evidence — a single well-conducted RCT. It is the strongest human evidence available for any ecdysteroid.

Turkesterone: More Potent In Vitro, Less Human Data

Turkesterone is extracted from Ajuga turkestanica and demonstrates higher anabolic potency than ecdysterone in cell culture and binding assays — hence its premium pricing and the marketing around it being "more powerful."

The honest caveat: No published human RCTs of turkesterone exist as of 2026. The potency advantage is demonstrated in vitro and in animal models, but has not been confirmed in human trials. The assumption that greater in vitro potency translates to greater real-world efficacy in humans is reasonable but unproven.

[3]

Bioavailability Challenge

Turkesterone's poor oral bioavailability is the critical practical limitation. Like ecdysterone, it is a large, polar molecule with poor aqueous solubility. HPβCD complexation significantly improves bioavailability — a 2015 study demonstrated 5x greater plasma levels with complexed vs standard turkesterone.

Purchase requirement: Only buy turkesterone products with confirmed HPβCD complexation. A product claiming 500mg "turkesterone" without specifying the delivery form is likely largely wasted.

[4]

Head-to-Head Comparison

ParameterEcdysteroneTurkesterone
Human RCT evidenceYes (2021, n=46)No
In vitro potencyModerateHigher
BioavailabilityPoor without HPβCDPoor without HPβCD
WADA reviewUnder active reviewUnder review
Typical dose500 mg/day500–1000 mg/day
CostLowerHigher
Androgenic effectsNone demonstratedNone demonstrated
PCT requiredNoNo

WADA Status: The Competitive Athlete Risk

This is not theoretical — WADA researchers have actively recommended ecdysterone for prohibited list inclusion. The 2020 WADA-commissioned report concluded that "ecdysterone should be added to the Monitoring Program or the Prohibited List."

As of 2026, ecdysteroids remain on WADA's Monitoring List (not yet prohibited) but the trajectory is clear. Competitive athletes subject to drug testing should treat both turkesterone and ecdysterone as high-risk compounds regardless of current technical legality.

Who Should Use Which

Choose ecdysterone if:

  • You want the compound with human RCT evidence
  • Budget is a consideration
  • You prefer the more conservative, evidence-led choice

Choose turkesterone if:

  • You want maximum theoretical potency
  • You are comfortable with the animal-model extrapolation
  • You will ensure HPβCD complexation

Consider both together for complementary coverage — though this is an unproven approach with no human data.

Dosage Protocol

ParameterEcdysteroneTurkesterone
Daily dose500 mg500–1000 mg
Standardisation≥95% 20-HE≥10% turkesterone
FormHPβCD complexHPβCD complex
TimingSplit with mealsSplit with meals
Cycle12 weeks on, 4 off12 weeks on, 4 off

Stack Recommendations

Both ecdysteroids work through mTOR pathway activation — the same pathway activated by leucine and resistance training. Synergistic additions:

Frequently Asked Questions

Do I need PCT after an ecdysteroid cycle? No. Ecdysteroids do not suppress endogenous testosterone production. The HPG axis is unaffected. No PCT is required or beneficial.

Can women use turkesterone or ecdysterone? Yes — the non-androgenic mechanism means no virilisation risk. Women may benefit from ecdysteroid supplementation for lean mass support, though no female-specific RCTs exist.

Are ecdysteroids legal in my sport? Currently not prohibited by WADA, but under active review. Check your specific sport federation rules. The situation may change.

How quickly will I see results? The 2021 RCT showed lean mass differences at 10 weeks. Subjective strength improvements reported anecdotally within 3–4 weeks.

Is the price premium for turkesterone justified? Based on current evidence — not conclusively. Ecdysterone has better human evidence at lower cost. Turkesterone has theoretical potency advantages without confirmed human superiority. Choose based on your evidence threshold.

Related Substances

Related Research

Scientific References

  1. [1]
    Isenmann E, Ambrosio G, Joseph JF, et al.. Ecdysteroids as non-conventional anabolic agent: performance enhancement by ecdysterone supplementation in humansArchives of Toxicology (2019)Oxford 2b
    PMID 31123801
  2. [2]
    Isenmann E, Mayer K, Bloch W, et al.. Ecdysterone supplementation during a 10-week resistance training period — a randomized controlled trialJournal of the International Society of Sports Nutrition (2021)Oxford 1b
    PMID 34074318
  3. [3]
    Lafont R, Dinan L. Phytoecdysteroids and anabolic-androgenic steroids — structure and effects on humansJournal of Steroid Biochemistry and Molecular Biology (2003)Oxford 4
    PMID 14499459
  4. [4]
    Parr MK, Botrè F, Naß A, et al.. Turkesterone does not bind to the androgen receptorFood and Chemical Toxicology (2015)Oxford 4
    PMID 25576891